Expanding the screening for diabetes in pregnancy: overmedicalization or the right thing to do?

Affiliations

¹ Dr. Saade is from the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, TX; e-mail: gsaade@utmb.edu.

Editorial

George R Saade. Obstet Gynecol. 2013 Aug.

. 2013 Aug;122(2 Pt 1):195-197.

doi: 10.1097/AOG.0b013e31829e42c3.

¹ Dr. Saade is from the Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, the University of Texas Medical Branch at Galveston, Galveston, TX; e-mail: gsaade@utmb.edu.

No abstract available

Comment on

National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013.
[No authors listed] [No authors listed] Obstet Gynecol. 2013 Aug;122(2 Pt 1):358-369. doi: 10.1097/AOG.0b013e31829c3e64. Obstet Gynecol. 2013. PMID: 23969806 No abstract available.

1. National Institutes of Health Consensus Development Conference Panel. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4–6, 2013. Obstet Gynecol 2013;122:358–69.
1. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, et al.. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86.
1. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al.. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48.
1. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502.